The Medical Week Baden-Baden is the forum for doctors and therapists who offer naturopathic therapies with full conviction. And it is a platform for all providers who are committed to the success of naturopathic therapy. An advanced training event between tradition and innovation, between discourse and experience. But above all, the Medical Week Baden-Baden achieves one thing: it brings together the passion of all those who are committed to naturopathy in the interests of patients.    

The DGfAN is one of the leading societies in Germany and Europe and offers with its training, advanced training and continuing education programs the basis of a practical, future-oriented integrative holistic medicine.  

For cancer and chronic diseases, hyperthermia is now more than just a glimmer of hope for improving the prognosis. Because hyperthermia can save, prolong and significantly improve lives. Innovations and latest technologies make it possible. Randomized studies prove it. The significance of this therapy should be much higher and absolutely needs more attention and support. The annual symposium also serves this purpose.

Promotion of applied research in physics, mechanical engineering and biological and clinical sciences related to hyperthermia in Europe.

The Gesellschaft für Biologische Krebsabwehr e.V. informs cancer patients and their relatives about proven naturopathic therapies for cancer.  

Modern naturopathy does not see itself as the antithesis of conventional medicine: it complements, expands and integrates its methods, it does not replace them. Modern naturopathy is complementary and integrative, not alternative. In the center of all efforts is always the human being and in the beginning always the committed and informed therapist. This is the focus of our journal "Die Naturheilkunde".

KANNE BROTTRUNK® - an important therapeutic agent in daily use on patients.

Der Partner für Maintrac®  

CellTrend ist ein Biotechnologieunternehmen, welches als Auftragsforschungs-Institut (CRO) im Auftrag der pharmazeutischen Industrie arbeitet Es werden zellbasierte Bio-Assays zur Wirkstoffforschung und für toxikologische Untersuchungen durchgeführt. Der zweite Schwerpunkt sind Immuno-Assays. Es werden neue Biomarker etabliert und ELISAs entwickelt, produziert und vertrieben.